ReviewFrontiers in pharmacology2026

Direct NLRP3 inflammasome inhibitors for cardiovascular therapeutics: a comparative review of synthetic and natural candidates.

Dong Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.